A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties.
暂无分享,去创建一个
Jun Qin | Gerard Manning | Roger J Daly | Christine L Gee | J. Qin | G. Manning | P. Eyers | M. Reese | O. Silvennoinen | C. Gee | N. Jura | R. Daly | D. Ungureanu | S. Elowe | Ling Liu | I. Lucet | Qingwei Zhang | Henrik M. Hammarén | James M. Murphy | S. N. Young | F. P. Bailey | L. Varghese | Kelan Chen | A. Tripaydonis | K. Fukuda | Z. Nimchuk | M. B. Mudgett | J. Babon | Sabine Elowe | Olli Silvennoinen | Isabelle S Lucet | Kelan Chen | Patrick A Eyers | Natalia Jura | James M Murphy | Mary Beth Mudgett | Samuel N Young | Leila N Varghese | Jeffrey J Babon | Daniela Ungureanu | Qingwei Zhang | Michael L Reese | Fiona P Bailey | Henrik Hammaren | Anne Tripaydonis | Koichi Fukuda | Zachary Nimchuk | Ling Liu | Anne Tripaydonis | Zachary L. Nimchuk | Samuel N. Young
[1] G. Drewes,et al. Affinity profiling of the cellular kinome for the nucleotide cofactors ATP, ADP, and GTP. , 2013, ACS chemical biology.
[2] Paul T. Tarr,et al. An Evolutionarily Conserved Pseudokinase Mediates Stem Cell Production in Plants , 2011, Plant Cell.
[3] J. Yates,et al. Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression , 2010, Proceedings of the National Academy of Sciences.
[4] Gerard Manning,et al. Structural and Functional Diversity of the Microbial Kinome , 2007, PLoS biology.
[5] Stefan N. Constantinescu,et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera , 2005, Nature.
[6] M. Lemmon,et al. Assessing the range of kinase autoinhibition mechanisms in the insulin receptor family , 2012, The Biochemical journal.
[7] T. Hunter,et al. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. , 1988, Science.
[8] R. Bamert,et al. Production and crystallization of recombinant JAK proteins. , 2013, Methods in molecular biology.
[9] Ji Luo,et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis , 2012, Proceedings of the National Academy of Sciences.
[10] P. McPherson,et al. Scyl1, Mutated in a Recessive Form of Spinocerebellar Neurodegeneration, Regulates COPI-mediated Retrograde Traffic*♦ , 2008, Journal of Biological Chemistry.
[11] Tony Pawson,et al. Temporal regulation of EGF signaling networks by the scaffold protein Shc1 , 2013, Nature.
[12] W. Alexander,et al. Insights into the evolution of divergent nucleotide-binding mechanisms among pseudokinases revealed by crystal structures of human and mouse MLKL. , 2014, The Biochemical journal.
[13] D. V. van Aalten,et al. Pseudokinases-remnants of evolution or key allosteric regulators? , 2010, Current opinion in structural biology.
[14] Stefan Knapp,et al. Structure of the Pseudokinase VRK3 Reveals a Degraded Catalytic Site, a Highly Conserved Kinase Fold, and a Putative Regulatory Binding Site , 2009, Structure.
[15] Alma L. Burlingame,et al. A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK , 2011, Nature.
[16] J. Kuriyan,et al. The Conformational Plasticity of Protein Kinases , 2002, Cell.
[17] G. Martin,et al. Xanthomonas T3S Effector XopN Suppresses PAMP-Triggered Immunity and Interacts with a Tomato Atypical Receptor-Like Kinase and TFT1[W] , 2009, The Plant Cell Online.
[18] Jonathan Bard,et al. Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. , 2004, Analytical biochemistry.
[19] D. Goeddel,et al. Membrane guanylate cyclase is a cell-surface receptor with homology to protein kinases , 1988, Nature.
[20] J. Boothroyd,et al. Bradyzoite Pseudokinase 1 Is Crucial for Efficient Oral Infectivity of the Toxoplasma gondii Tissue Cyst , 2013, Eukaryotic Cell.
[21] Sandra A. Moore,et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. , 2005, Cancer cell.
[22] G. Labesse,et al. ROP2 from Toxoplasma gondii: a virulence factor with a protein-kinase fold and no enzymatic activity. , 2008, Structure.
[23] Maria Deak,et al. Structure of the LKB1-STRAD-MO25 Complex Reveals an Allosteric Mechanism of Kinase Activation , 2009, Science.
[24] Marc Vidal,et al. COT/MAP3K8 drives resistance to RAF inhibition through MAP kinase pathway reactivation , 2010, Nature.
[25] John Kuriyan,et al. Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3 , 2009, Proceedings of the National Academy of Sciences.
[26] A. R. Shenoy,et al. The kinase homology domain of receptor guanylyl cyclase C: ATP binding and identification of an adenine nucleotide sensitive site. , 2006, Biochemistry.
[27] S. Nelson,et al. SGK196 Is a Glycosylation-Specific O-Mannose Kinase Required for Dystroglycan Function , 2013, Science.
[28] A. Fraser,et al. Nuclear receptor binding protein 1 regulates intestinal progenitor cell homeostasis and tumour formation , 2012, The EMBO journal.
[29] Qingshan Li,et al. Identification of an Acquired JAK2 Mutation in Polycythemia Vera* , 2005, Journal of Biological Chemistry.
[30] Toru Okamoto,et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. , 2013, Immunity.
[31] H C Clevers,et al. Activation of the tumour suppressor kinase LKB1 by the STE20‐like pseudokinase STRAD , 2003, The EMBO journal.
[32] Chae Un Kim,et al. Structure of a pseudokinase domain switch that controls oncogenic activation of Jak kinases , 2013, Nature Structural &Molecular Biology.
[33] L. Berg,et al. A new member of the Eph family of receptors that lacks protein tyrosine kinase activity. , 1996, Oncogene.
[34] R. Norton,et al. Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity. , 2012, Immunity.
[35] G. Stark,et al. IRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family* , 1999, The Journal of Biological Chemistry.
[36] Ying Jin,et al. Deletion of STK40 Protein in Mice Causes Respiratory Failure and Death at Birth* , 2013, The Journal of Biological Chemistry.
[37] R. Radhakrishnan,et al. ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation , 2010, Proceedings of the National Academy of Sciences.
[38] M. Mann,et al. Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. , 2008, Molecular cell.
[39] J. Boothroyd,et al. A Toxoplasma gondii Pseudokinase Inhibits Host IRG Resistance Proteins , 2012, PLoS biology.
[40] Yibing Shan,et al. Crystal structures of the Jak2 pseudokinase domain and the pathogenic mutant V617F , 2012, Nature Structural &Molecular Biology.
[41] T. Südhof,et al. CASK Functions as a Mg2+-Independent Neurexin Kinase , 2008, Cell.
[42] M. Lemmon,et al. Receptor tyrosine kinases with intracellular pseudokinase domains. , 2013, Biochemical Society transactions.
[43] P. Eyers,et al. Dawn of the dead: protein pseudokinases signal new adventures in cell biology. , 2013, Biochemical Society transactions.
[44] S. Knapp,et al. Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase. , 2005, Journal of medicinal chemistry.
[45] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[46] C. Gee,et al. A Phosphorylated Pseudokinase Complex Controls Cell Wall Synthesis in Mycobacteria , 2012, Science Signaling.
[47] Naveid A Ali,et al. Involvement of Lyn and the atypical kinase SgK269/PEAK1 in a basal breast cancer signaling pathway. , 2013, Cancer research.
[48] Jihwan Song,et al. Cloning and characterization of the full-length mouse Ptk7 cDNA encoding a defective receptor protein tyrosine kinase. , 2004, Gene.
[49] J. Qin,et al. Biochemical, Proteomic, Structural, and Thermodynamic Characterizations of Integrin-linked Kinase (ILK) , 2011, The Journal of Biological Chemistry.
[50] P. Campbell,et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders , 2005, The Lancet.
[51] Florian Gnad,et al. Large-scale Proteomics Analysis of the Human Kinome , 2009, Molecular & Cellular Proteomics.
[52] James M. Murphy,et al. In vitro JAK kinase activity and inhibition assays. , 2013, Methods in molecular biology.
[53] L. Trusolino,et al. ROR1 is a pseudokinase that is crucial for MET-driven tumorigenesis , 2011, BMC Proceedings.
[54] C. Hovens,et al. RYK, a receptor tyrosine kinase-related molecule with unusual kinase domain motifs. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[55] Eduardo Pauls,et al. Two Phases of Inflammatory Mediator Production Defined by the Study of IRAK2 and IRAK1 Knock-in Mice , 2013, The Journal of Immunology.
[56] H. Matsuoka,et al. Expression of a kinase-defective Eph-like receptor in the normal human brain. , 1997, Biochemical and biophysical research communications.
[57] O. Silvennoinen,et al. Regulation of the Jak2 Tyrosine Kinase by Its Pseudokinase Domain , 2000, Molecular and Cellular Biology.
[58] S. Hubbard,et al. The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling , 2011, Nature Structural &Molecular Biology.
[59] D. Hilton,et al. A convenient method for preparation of an engineered mouse interleukin-3 analog with high solubility and wild-type bioactivity , 2010, Growth factors.
[60] Sharmeela Kaushal,et al. KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer. , 2012, Cancer research.
[61] T. Roberts,et al. The conserved lysine of the catalytic domain of protein kinases is actively involved in the phosphotransfer reaction and not required for anchoring ATP. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[62] R. Stewart,et al. TNP-ATP and TNP-ADP as probes of the nucleotide binding site of CheA, the histidine protein kinase in the chemotaxis signal transduction pathway of Escherichia coli. , 1998, Biochemistry.
[63] S. Blacklow,et al. Transformation by Tribbles homolog 2 (Trib2) requires both the Trib2 kinase domain and COP1 binding. , 2010, Blood.
[64] Bernhard Kuster,et al. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors , 2007, Nature Biotechnology.
[65] Mathijs Vleugel,et al. The vertebrate mitotic checkpoint protein BUBR1 is an unusual pseudokinase. , 2012, Developmental cell.
[66] J. Qin,et al. The pseudoactive site of ILK is essential for its binding to alpha-Parvin and localization to focal adhesions. , 2009, Molecular cell.
[67] Mario Cazzola,et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. , 2005, The New England journal of medicine.
[68] J. Boothroyd,et al. A Conserved Non-canonical Motif in the Pseudoactive Site of the ROP5 Pseudokinase Domain Mediates Its Effect on Toxoplasma Virulence* , 2011, The Journal of Biological Chemistry.
[69] G. Barton,et al. Emerging roles of pseudokinases. , 2006, Trends in cell biology.
[70] R. Fässler,et al. Integrin-linked kinase is an adaptor with essential functions during mouse development , 2009, Nature.
[71] B. Druker,et al. Crosstalk between ROR1 and the Pre-B cell receptor promotes survival of t(1;19) acute lymphoblastic leukemia. , 2012, Cancer cell.
[72] D. V. van Aalten,et al. ATP and MO25α Regulate the Conformational State of the STRADα Pseudokinase and Activation of the LKB1 Tumour Suppressor , 2009, PLoS biology.
[73] Chao Zhang,et al. Structure and substrate recruitment of the human spindle checkpoint kinase Bub1. , 2008, Molecular cell.
[74] Osamu Takeuchi,et al. Sequential control of Toll-like receptor–dependent responses by IRAK1 and IRAK2 , 2008, Nature Immunology.
[75] H. Lee,et al. Characterization of the human full-length PTK7 cDNA encoding a receptor protein tyrosine kinase-like molecule closely related to chick KLG. , 1996, Journal of biochemistry.
[76] I. Lucet,et al. Techniques to examine nucleotide binding by pseudokinases. , 2013, Biochemical Society transactions.